Literature DB >> 17364346

Hearing in women at menopause. Prevalence of hearing loss, audiometric configuration and relation to hormone replacement therapy.

Christina Hederstierna1, Malou Hultcrantz, Aila Collins, Ulf Rosenhall.   

Abstract

CONCLUSION: Hormone replacement therapy (HRT) may have a protective effect on hearing impairment in postmenopausal women. New guidelines for classification of audiometric configuration in age-related hearing loss are suggested.
OBJECTIVES: To describe prevalence of hearing loss and audiometric configuration in a group of middle-aged women with respect to menopausal stage and HRT. SUBJECTS AND METHODS: A total of 143 women around menopause were sampled through the Swedish population register. The mean hearing threshold levels were compared according to menopausal status. The audiograms in the 57 women with hearing loss were classified according to audiometric configuration.
RESULTS: In all, 57 women (40%) had any kind of hearing loss; 42 had very minute hearing loss; 15 had a 4FA (average of thresholds at 0.5, 1, 2, and 4 kHz) of at least 20-39 dB HL in at least one ear. Two of these had a 4FA of 40-69 dB HL in at least one ear. The most common configurations were: gently sloping (47%), steeply sloping (14%), and high-frequency U-shaped (14%). The postmenopausal women who were not on HRT had poorer hearing mainly at 2 and 3 kHz, compared with pre- and perimenopausal women, and postmenopausal women on HRT.

Entities:  

Mesh:

Year:  2007        PMID: 17364346     DOI: 10.1080/00016480600794446

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  20 in total

1.  Biomarkers of Systemic Inflammation and Risk of Incident Hearing Loss.

Authors:  Shruti Gupta; Sharon G Curhan; Gary C Curhan
Journal:  Ear Hear       Date:  2019 Jul/Aug       Impact factor: 3.570

2.  Hormone replacement therapy diminishes hearing in peri-menopausal mice.

Authors:  Katharine Price; Xiaoxia Zhu; Patricia F Guimaraes; Olga N Vasilyeva; Robert D Frisina
Journal:  Hear Res       Date:  2009-03-06       Impact factor: 3.208

3.  Menopause and postmenopausal hormone therapy and risk of hearing loss.

Authors:  Sharon G Curhan; A Heather Eliassen; Roland D Eavey; Molin Wang; Brian M Lin; Gary C Curhan
Journal:  Menopause       Date:  2017-09       Impact factor: 2.953

Review 4.  Auditory function and dysfunction: estrogen makes a difference.

Authors:  Amandine Delhez; Philippe Lefebvre; Christel Péqueux; Brigitte Malgrange; Laurence Delacroix
Journal:  Cell Mol Life Sci       Date:  2019-09-14       Impact factor: 9.261

5.  Analgesic use and the risk of hearing loss in women.

Authors:  Sharon G Curhan; Josef Shargorodsky; Roland Eavey; Gary C Curhan
Journal:  Am J Epidemiol       Date:  2012-08-29       Impact factor: 4.897

6.  Divergent aging characteristics in CBA/J and CBA/CaJ mouse cochleae.

Authors:  Kevin K Ohlemiller; Ashley R Dahl; Patricia M Gagnon
Journal:  J Assoc Res Otolaryngol       Date:  2010-08-13

7.  Interaction of tamoxifen and noise-induced damage to the cochlea.

Authors:  Jagan A Pillai; Jonathan H Siegel
Journal:  Hear Res       Date:  2011-09-02       Impact factor: 3.208

8.  Sex differences in hearing: Probing the role of estrogen signaling.

Authors:  Benjamin Z Shuster; Didier A Depireux; Jessica A Mong; Ronna Hertzano
Journal:  J Acoust Soc Am       Date:  2019-06       Impact factor: 1.840

Review 9.  Cellular targets of estrogen signaling in regeneration of inner ear sensory epithelia.

Authors:  Jennifer S McCullar; Elizabeth C Oesterle
Journal:  Hear Res       Date:  2009-02-06       Impact factor: 3.208

Review 10.  Estrogenic modulation of auditory processing: a vertebrate comparison.

Authors:  Melissa L Caras
Journal:  Front Neuroendocrinol       Date:  2013-07-31       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.